Heron Therapeutics Inc
NASDAQ:HRTX
| Market Cap (Intraday) | 190.13M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 21 |
| 10-Day MA | $1.30 |
| 50-Day MA | $1.64 |
| 200-Day MA | $1.84 |
Heron Therapeutics Inc Stock, NASDAQ:HRTX
100 Regency Forest Drive, Suite 300, Cary, North Carolina 27518
United States of America
Phone: +1.858.251.4400
Number of Employees: 122
Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.